| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.009 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |